[1]
Warham, W. et al. 2025. Febuxostat In Hyperuricemic Heart Failure: A Systematic Review of Cardiovascular Outcomes and Safety. International Journal of Health and Pharmaceutical (IJHP). 5, 4 (Nov. 2025), 673–686. DOI:https://doi.org/10.51601/ijhp.v5i4.469.